{
  "n_pages": 37,
  "title_page": {
    "title": "Poisons, Opium And Dangerous Drugs (Amendment)  Act",
    "num": "41",
    "year": "2022",
    "date_certified": "2022-11-23",
    "date_published": "2022-11-25",
    "price": 60.0,
    "price_postage": 35.0
  },
  "body_pages": {
    "preamble": [
      "[Certified On 23Rd Of November, 2022]",
      "L.D.O. 5/2021",
      "A N   A Ct   To   Amend   The  P Oisons , O Pium   And  D Angerous D Rugs  O Rdinance  (C Hapter  218)",
      "Be It Enacted By The Parliament Of The Democratic Socialist Republic Of Sri Lanka As Follows:-"
    ],
    "pre_section_list": [
      {
        "class_name": "ActL1Section",
        "num": "1",
        "text": "This Act may be cited as the Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022.",
        "pre_block_list": [
          "Short title"
        ],
        "child_level_list": []
      },
      {
        "class_name": "ActL1Section",
        "num": "2",
        "text": "Section 54 A  of the Poisons, Opium and Dangerous Drugs Ordinance (Chapter 218) (hereinafter referred to as the principal enactment) is hereby amended as follows: -",
        "pre_block_list": [
          "Amendment of section 54 A  of Chapter 218"
        ],
        "child_level_list": [
          {
            "class_name": "ActL2Subsection",
            "num": "1",
            "text": "by the re-numbering of section 54 A  as subsection (1) of that section;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL2Subsection",
            "num": "2",
            "text": "in the renumbered subsection (1), by the repeal of all the words from In this section: - to the end of that section;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL2Subsection",
            "num": "3",
            "text": "by the insertion immediately after subsection (1), of the following new subsections: -",
            "pre_block_list": [
              "(2) In any proceedings under subsection (1), a certificate signed by an authorized analyst confirming -"
            ],
            "child_level_list": [
              {
                "class_name": "ActL3Paragraph",
                "num": "a",
                "text": "the type of the dangerous drug; and",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL3Paragraph",
                "num": "b",
                "text": "that the gross weight of such dangerous drug is two grammes or less,",
                "pre_block_list": [
                  "shall be  prima facie  evidence of the facts stated therein and the pure quantity of such dangerous drug shall be deemed to be not exceeding two grammes.",
                  "(3)  In this section -",
                  "Goverment Analyst means the person holding office as the Goverment Analyst for the time being and includes an Additional, Deputy, Senior Assistant or Assistant Government Analyst and any person appointed to act as the Government Analyst or an Additional, Deputy, Senior Assistant or Assistant Government Analyst;",
                  "manufacture in relation to a dangerous drug includes any process of producing such drug and the refining or transformation of one drug into another;",
                  "traffick means-",
                  "( a ) to sell, give, procure, store, administer, transport, send, deliver or distribute; or",
                  "( b ) to offer to do anything specified in paragraph ( a )",
                  "",
                  "Amendment of section 77 A  of the principal enactment"
                ],
                "child_level_list": []
              }
            ]
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "3",
        "text": "Section 77 A  of the principal enactment is hereby amended as follows: -",
        "pre_block_list": [],
        "child_level_list": [
          {
            "class_name": "ActL2Subsection",
            "num": "1",
            "text": "by the repeal of subsections (2), (3) and (4) of that section and the substitution therefor of the following: -",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL2Subsection",
            "num": "2",
            "text": "Where the Government Analyst has made an examination of any drug, substance, article or preparation submitted to him under",
            "pre_block_list": [
              "subsection (1), he shall, within a period not  exceeding twelve months from the date of such  submission,  send a report setting out the result  of his examination to the Magistrate or any  other competent court which has the jurisdiction  to try an offence committed under Chapter III  or Chapter V of this Ordinance, with copies to  the police officer who submitted such drug,  substance, article and preparation or any portion  or sample for examination and to the Police  Narcotics Bureau."
            ],
            "child_level_list": []
          },
          {
            "class_name": "ActL2Subsection",
            "num": "3",
            "text": "A report submitted to the Magistrate or  any other competent court under subsection (2)  shall be  prima facie  evidence in any inquiry,  trial or other proceeding conducted under this  Ordinance.",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL2Subsection",
            "num": "4",
            "text": "Where any person raises an issue in  respect of the opinion of the Government  Analyst specified in the report referred to in  subsection (3) in any inquiry, trial or other  proceeding, the burden of proving the fact that  such report is inaccurate shall lie on the person  who raises such issue",
            "pre_block_list": [
              "",
              "(2) by the addition immediately after subsection (4) of that section, of the following: -"
            ],
            "child_level_list": []
          },
          {
            "class_name": "ActL2Subsection",
            "num": "5",
            "text": "",
            "pre_block_list": [],
            "child_level_list": [
              {
                "class_name": "ActL3Paragraph",
                "num": "a",
                "text": "Where the Magistrate or the judge of any competent court having the jurisdiction to try the offence committed under Chapter III or Chapter V, is of the opinion that such drug, substance, article or preparation would become necessary in evidence during the proceedings before such court in respect of any offence, he shall order the Police Narcotics Bureau or any person authorized by the Magistrate or the Judge of such competent court to photograph such",
                "pre_block_list": [
                  "drug, substance, article or preparation, including the packages and seals, and to preserve the necessary evidance including packages and seals and to order the Police Narcotics Bureau or any person authorized by the Magistrate or the Judge of such competent court to destroy the same in the presence of the Registrar of such court, the prosecuting Counsel or the Police Officer who conducts the prosecution or his representative and the defence Counsel or his representative."
                ],
                "child_level_list": []
              },
              {
                "class_name": "ActL3Paragraph",
                "num": "b",
                "text": "The Police Narcotics Bureau or the person authorized by the Magistrate or the judge of the competent court, as the case may be, shall take the photographs in terms of the order made under paragraph ( a ) and forward such photographs and the necessary evidence including packages and seals forthwith to the relevant court.",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL3Paragraph",
                "num": "c",
                "text": "The Police Narcotics Bureau or any person authorized by the Magistrate or the judge of such competent court shall under the supervision of the Magistrate or the judge of the competent court, as the case may be, destroy or cause to be destroyed such drug, substance, article or preparation in compliance with the order made by such Magistrate or the judge as the case may be, under paragraph ( a ) within a period of two months of the date of such order and shall forthwith submit a report relating to such destruction to the relevant court.",
                "pre_block_list": [],
                "child_level_list": []
              }
            ]
          },
          {
            "class_name": "ActL2Subsection",
            "num": "6",
            "text": "The Minister assigned the subject of Justice may, with the concurrence of the Judicial Service Commission prescribe by regulation, the mechanism of disposal of such drug, substance, article or preparation specified in subsection (5)",
            "pre_block_list": [
              "",
              "Replacement of section 83 of the principal enactment No bail for an offence under sections 54 A  and 54 B except in exceptional circumstances"
            ],
            "child_level_list": []
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "4",
        "text": "Section 83 of the   principal enactment   is hereby repealed and the following section is substituted therefor:-",
        "pre_block_list": [
          "83. (1) Subject to the provisions of sections 84, 85 and subsection (2) of this section, a person suspected or accused of an offence under sections 54 A  and 54 B  of this Ordinance, shall not be released on bail by the High  Court  except  in  exceptional circumstances."
        ],
        "child_level_list": [
          {
            "class_name": "ActL2Subsection",
            "num": "2",
            "text": "Notwithstanding the provisions of sections 84 and 85, a person suspected or accused of  an offence under subsection (1) of section 54 A  and section 54 B -",
            "pre_block_list": [],
            "child_level_list": [
              {
                "class_name": "ActL3Paragraph",
                "num": "a",
                "text": "of which the pure quantity of the dangerous drug, trafficked, imported, exported or possessed is ten grammes or above in terms of the report issued by the Government Analyst under section 77 A  ; and",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL3Paragraph",
                "num": "b",
                "text": "which is punishable with death or life imprisoment,",
                "pre_block_list": [
                  "shall not be released on bail except by the Court of Appeal in exceptional circumstances."
                ],
                "child_level_list": []
              }
            ]
          },
          {
            "class_name": "ActL2Subsection",
            "num": "3",
            "text": "For the purposes of this section dangerous drug means Morphine, Cocaine, Heroin and Methamphetamine",
            "pre_block_list": [
              ""
            ],
            "child_level_list": []
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "5",
        "text": "The following new sections are hereby inserted immediately after section 83 of the principal enactment, and shall have effect as sections 84, 85, 86 and 87 of that enactment :-",
        "pre_block_list": [
          "Insertion of new sections 84, 85, 86 and 87 in the principal enactment",
          "84. A suspect or an accused who has not been tried and has not been convicted and sentenced by a  C ourt under the provisions of subsection (1) of section 54 A  and section 54 B , shall not be detained in custody for a period exceeding twelve months from the date of his arrest.",
          "No person to be detained for more than twelve months in custody",
          "85. Notwithstanding the provisions of section 84, on application made in that behalf by the Attorney-General to the High Court established under Article 105 or a High Court established by Article 154 P  of the Constitution such court may, for good and sufficient reasons that shall be recorded, order that a suspect or an accused who has not been tried and has not been convicted and sentenced by a  C ourt under the provisions of subsection (1) of section 54 A and section 54 B , be detained in custody for a period in excess of twelve months:",
          "Extension of the  period of detention",
          "Provided that, the period of detention ordered under this section, shall not in any case exceed three months at a time and twenty four months in the aggregate.",
          "86. (1) A person who is alleged to have committed an offence under section 52, section 54 or paragraphs ( b ), ( c ) or ( d ) of subsection (1) of section 54 A  (in this section referred to as the offender) shall not be liable for prosecution for an offence under the said provision in the following circumstances: -",
          "Voluntary admission to medical treatment for de-addiction and rehabilitation",
          "( a ) where the quantity of the dangerous drug involved in the commission of the offence is less than one gramme;",
          "( b ) where such person seeks to undergo medical treatment for de-addiction and rehabilitation; and",
          "( c ) where the Attorney-General has sanctioned the staying of the prosecution."
        ],
        "child_level_list": [
          {
            "class_name": "ActL2Subsection",
            "num": "2",
            "text": "",
            "pre_block_list": [],
            "child_level_list": [
              {
                "class_name": "ActL3Paragraph",
                "num": "a",
                "text": "The Officer-in- Charge of the relevant Police Station, who conducts the investigation on the offender shall refer the offender to be examined by a Government Medical Officer to obtain a medical report on the extent of the drug dependency of such person.",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL3Paragraph",
                "num": "b",
                "text": "If the medical report obtained under paragraph ( a ) confirms that the offender is a drug dependent person, the Officer-in-Charge of the Police Station shall refer such person to residential or non-residential treatment or rehabilitation in a Treatment and Rehabilitation Centre designated in terms of the Drug Dependent Persons (Treatment and Rehabilitation) Act, No. 54 of 2007.",
                "pre_block_list": [],
                "child_level_list": []
              }
            ]
          },
          {
            "class_name": "ActL2Subsection",
            "num": "3",
            "text": "Notwithstanding the preceding provisions of this section, any offender who fails to complete the treatment referred to in paragraph ( b ) of subsection (2) shall be liable to be prosecuted under section 52, section 54 or subsection (1) of section 54 A , as the case may be.",
            "pre_block_list": [
              "87. Any person under the age of eighteen years who commits an offence punishable with death or life imprisonment under section 52, section 54, paragraphs ( b ), ( c ) and ( d ) of subsection (1) of section 54 A  and 54 B  shall not be punished with death or life imprisonment and shall only be liable for imprisonment for a term not exceeding ten years with compulsory rehabilitation and five years probation under the Probation of Offenders Ordinance (Chapter 23)",
              "",
              "Probation for young offenders under eighteen years of age"
            ],
            "child_level_list": []
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "6",
        "text": "The Third Schedule to the principal enactment is hereby amended as follows:-",
        "pre_block_list": [
          "Amendment of the Third Schedule to the principal enactment"
        ],
        "child_level_list": [
          {
            "class_name": "ActL2Subsection",
            "num": "1",
            "text": "by the substitution, for Group B of Part I of that Schedule, of the following:-",
            "pre_block_list": [
              "GROUP B (sections 48, 51 and 68)",
              "Drugs, substances, articles or preparations to which the provisions as to importation, exportation and wholesale and retail trade apply.",
              "S ECTION  1",
              "1  Acetorphine 3- O -acetyltetrahydro-7  -(1-hydroxy-1- methylbutyl)-6,14- endo - ethenooripavine (derivative of thebaine)",
              "2  Acetyl- alpha - N -[1-(  -methylphenethyl)-4- methylfentanyl piperidyl]acetanilide",
              "3  Acetylfentanyl N -Phenyl- N -[1-(2-phenylethyl)-4- piperidinyl]acetamide",
              "4  Acetylmethadol 3-acetoxy-6-dimethylamino-4,4- diphenylheptane",
              "5  Acryloylfentanyl N -phenyl- N -[1-(2- phenylethyl)",
              "(acrylfentanyl) piperidin-4-yl] prop- 2-enamide",
              "6  Alfentanil N -[1-[2-(4-ethyl-4,5-dihydro-5- oxo-1 H -tetrazol-1-yl)ethyl]-4- (methoxymethyl)-4-piperidinyl]- N -phenylpropanamide",
              "7  AH-7921 3,4-Dichloro- N -{[1-(dimethylamino) cyclohexyl] methyl}benzamide",
              "8  Allylprodine 3-allyl-1-methyl-4-phenyl-4- propionoxypiperidine",
              "9  Alphacetyl  -3-acetoxy-6-dimethylamino- methadol 4,4-diphenylheptane",
              "10 Alphameprodine  -3-ethyl-1-methyl-4-phenyl-4- propionoxypiperidine",
              "11 Alphamethadol  -6-dimethylamino-4,4 diphenyl- 3-heptanol",
              "12  Alpha - N- [1-(  -methylphenethyl)-4-",
              "Methylfentanyl piperidyl]propionanilide",
              "13  Alpha -",
              "Methylthiofentanyl N- [1-[1-methyl-2-(2 thienyl)ethyl]-4- piperidyl]propionanilide",
              "14 Alphaprodine  -1,3-dimethyl-4-phenyl-4- propionoxypiperidine",
              "15 Anileridine 1- p -aminophenethyl-4- phenylpiperidine-4-carboxylic acid ethyl ester",
              "16 Benzethidine 1-(2-benzyloxyethyl)-4- phenylpiperidine-4-carboxylic acid ethyl ester",
              "17 Benzylmorphine 3-benzylmorphine",
              "",
              "18 Betacetylmethadol   -3-acetoxy-6-dimethylamino- 4,4-diphenylheptane",
              "19  beta -Hydroxyfentanyl N- [1-( -hydroxyphenethyl)-4-",
              "",
              "piperidyl] propionanilide",
              "20  beta -Hydroxy-3- N -  [ 1 - ( - h y d r o x y p h e n e t h y l ) - 3 - methylfentanyl methyl-4-piperidyl]propionanilide",
              "",
              "21 Betameprodine -3-ethyl-1-methyl-4-phenyl-4- propionoxypiperidine",
              "",
              "22 Betamethadol   -6-dimethylamino-4,4-diphenyl- 3-heptanol",
              "",
              "23 Betaprodine   -1,3-dimethyl-4-phenyl-4- propionoxypiperidine",
              "",
              "24 Bezitramide 1-(3-cyano-3,3-diphenylpropyl)-4-(2- oxo-3-propionyl-1- benzimidazolinyl) piperidine 25 Butyrfentanyl N- phenyl- N- [1-(2-phenylethyl)-4- piperidinyl]butanamide",
              "26 Cannabis the flowering or fruiting tops of the cannabis plant (resin not extracted)",
              "27 Cannabis Resin, the separated resin, crude or purified, Extracts and obtained from the cannabis plant Tinctures",
              "28 Carfentanil Methyl 1-(2-phenylethyl)-4- [phenyl (propanoyl) amino] piperidine- 4- carboxylate 29 Clonitazene 2-( p -chlorobenzyl)-1- diethylaminoethyl-5- nitrobenzimidazole",
              "30 Coca leaf the leaf of the coca bush (plant material), except a leaf from which all ecgonine, cocaine and any  other ecgonine alkaloids have been removed",
              "31 Cocaine methyl ester of benzoylecgonine (an alkaloid found in coca leaves or prepared by synthesis from ecgonine) 32 Codoxime dihydrocodeinone-6- carboxymethyloxime (derivate of morphine)",
              "33 Concentrate of The material arising when parts of poppy straw any plant of the species Papaversomniferum  have entered a process for the concentration of the alkaloids 34 Cyclopropylfentanyl N -Phenyl- N -[1-(2-phenylethyl) piperidin-4- yl] cyclopropanecarboxamide",
              "35 Desomorphine Dihydrodesoxymorphine (derivative of morphine)",
              "36 Dextromoramide (+)-4-[2-methyl-4-oxo-3,3- diphenyl-4-(1-pyrrolidinyl) butyl] morpholine (dextro-rotatory isomer of moramide) 37 Diampromide N- [2-(methylphenethylamino)- propyl] propionanilide",
              "38 Diethylthiambutene 3-diethylamino-1,1-di-(2- thienyl)-1-butene",
              "39 Difenoxin 1-(3-cyano-3,3-diphenylpropyl)- 4-phenylisonipecotic acid",
              "40 Dihydroetorphine 7,8-dihydro-7  -[1-( R )-hydroxy-1- methylbutyl]-6,14- endo - ethanotetrahydrooripavine (derivative of etorphine) 41 Dihydromorphine (derivative of morphine)",
              "42 Dimenoxadol 2-dimethylaminoethyl-1-ethoxy- 1,1-diphenylacetate",
              "43 Dimepheptanol 6-dimethylamino-4,4-diphenyl-3- heptanol",
              "44 Dimethylthiambutene 3-dimethylamino-1,1-di-(2-thienyl)- 1-butene",
              "45 Dioxaphetyl ethyl-4-morpholino-2,2- butyrate diphenylbutyrate",
              "46 Diphenoxylate 1-(3-cyano-3,3-diphenylpropyl)-4- phenylpiperidine-4-carboxylic acid ethyl ester 47 Dipipanone 4,4-diphenyl-6-piperidine-3-heptanone",
              "48 Drotebanol 3,4-dimethoxy-17- methylmorphinan-6 ,14-diol",
              "",
              "49 Ecgonine its esters and derivatives which are convertible to ecgonine and cocaine",
              "50 Ethylmethylthiambutene 3-ethylmethylamino-1,1-di-(2- thienyl)-1-butene",
              "51 Etonitazene 1-diethylaminoethyl-2- p - ethoxybenzyl-5- nitrobenzimidazole",
              "52 Etorphine tetrahydro-7  -(1-hydroxy-1- methylbutyl)-6,14- endo - ethenooripavine (derivative of thebaine) 53 Etoxeridine 1-[2-(2-hydroxyethoxy)-ethyl]-4- phenylpiperidine-4-carboxylic acid ethyl ester",
              "54 Fentanyl 1-phenethyl-4- N- propionylanilinopiperidine",
              "55 4-Fluoroisobutyrfentanyl N-(4-fluorophenyl)-N-(1- (4- FIBF, pFIBF) phenetylpiperidin-4-yl)isobutyramide 56 Furanylfentanyl N -phenyl- N -[1-(2- phenylethyl)piperidin-4-yl]furan- 2-carboxamide",
              "57 Furethidine 1-(2-tetrahydrofurfuryloxyethyl)-4- phenylpiperidine-4-carboxylic acid ethyl ester 58 Heroin Diacetylmorphine",
              "59 Hydrocodone Dihydrocodeinone",
              "60 Hydromorphinol 14-hydroxydihydromorphine (derivative of morphine)",
              "61 Hydromorphone dihydromorphinone (derivative of morphine)",
              "62 Hydroxypethidine 4- m -hydroxyphenyl-1- methylpiperidine-4-carboxylic acid ethyl ester",
              "63 Isomethadone 6-dimethylamino-5-methyl-4,4- diphenyl-3-hexanone",
              "64 Ketobemidone 4- m -hydroxyphenyl-1-methyl-4- propionylpiperidine",
              "65 Levomethorphan (-)-3-methoxy- N- methylmorphinan",
              "66 Levomoramide (-)-4-[2-methyl-4-oxo-3,3- diphenyl-4-(1- pyrrolidinyl)butyl]morpholine",
              "67 Levophenacylmorphan (-)-3-hydroxy- N- phenacylmorphinan",
              "68 Levorphanol (-)-3-hydroxy- N- methylmorphinan",
              "69 Metazocine 2-hydroxy-2,5,9-trimethyl-6,7- benzomorphan",
              "70 Methadone 6-dimethylamino-4,4-diphenyl-3- heptanone",
              "71 Methadone 4-cyano-2-dimethylamino-4,4- Intermediate diphenylbutane",
              "72 Methoxyacetyl 2-Methoxy- N -phenyl- N -[1-(2- fentanyl phenylethyl)piperidin-4-yl] acetamide",
              "73 Methyldesorphine 6-methyl-     -deoxymorphine (derivative of morphine)",
              " 6",
              "74 Methyldihyd 6-methyldihydromorphine romorphine  (derivative of morphine)",
              "75 3-Methylfentanyl N- (3-methyl-1-phenethyl-4- piperidyl)propionanilide",
              "76 3-Methylthio N- [3-methyl-1-[2-(2- fentanyl thienyl) ethyl]-4- piperidyl]propionanilide",
              "77 Metopon 5-methyldihydromorphinone (derivative of morphine)",
              "78 Moramide 2-methyl-3- Intermediate morpholino-1,1-diphenylpropane carboxylic acid",
              "79 Morpheridine 1-(2-morpholinoethyl)-4- phenylpiperidine-4-carboxylic acid ethyl ester",
              "80 Morphine the principal alkaloid of opium and of opium poppy",
              "81 Morphine any other pentavalent Methobromide nitrogen morphinederivatives including in particular the morphine- N- oxide derivatives, one of which is codeine- N- oxide 82 Morphine- N- oxide A derivate of morphine",
              "83 MPPP 1-methyl-4-phenyl-4-piperidinol propionate (ester)",
              "84 MT-45 1-cyclohexyl-4-(1,2-diphenylethyl) piperazine",
              "85 Myrophine Myristylbenzylmorphine",
              "(derivate of morphine)",
              "86 Nicomorphine 3,6-dinicotinylmorphine (derivate of morphine)",
              "87 Noracymethadol ()-  -3-acetoxy-6-methylamino- 4,4-diphenylheptane",
              "88 Norlevorphanol (-)-3-hydroxymorphinan",
              "89 Normethadone 6-dimethylamino-4,4-diphenyl-3- hexanone",
              "90 Normorphine demethylmorphine (derivate of morphine)",
              "91 Norpipanone 4,4-diphenyl-6-piperidino-3- hexanone",
              "92 Ocfentanil N -(2-fluorophenyl)-2-methoxy- N - [1-(2-phenylethyl)piperidin-4-yl] acetamide",
              "93 Opium The coagulated juice of the opium poppy plant species Papaversomniferum L .",
              "94 Oripavine 3- O -demethylthebaine",
              "95 Orthofluorofentanyl N -(2-Fluorophenyl)- N - [1-(2-phenylethyl)piperidin-4-yl] propanamide",
              "96 Oxycodone 14-hydroxydihydrocodeinone (derivate of morphine)",
              "97 Oxymorphone 14-hydroxydihydromorphinone (derivate of morphine)",
              "98 Parafluorobutyryl N -(4-Fluorophenyl)- N - fentanyl [1-(2-phenylethyl)piperidin-4-yl] butanamide",
              "99  para -Fluorofentanyl 4-fluoro- N- (1-phenethyl-4- piperidyl)propionanilide",
              "100 PEPAP 1-phenethyl-4-phenyl-4- piperidinol acetate (ester)",
              "101 Pethidine 1-methyl-4-phenylpiperidine-4- carboxylic acid ethyl ester",
              "102 Pethidine 4-cyano-1-methyl-4- Intermediate A phenylpiperidine",
              "103 Pethidine 4-phenylpiperidine-4- Intermediate B carboxylic acid ethyl ester",
              "104 Pethidine 1-methyl-4-phenylpiperidine Intermediate C -4-carboxylic acid",
              "105 Phenadoxone 6-morpholino-4,4-diphenyl-3- heptanone",
              "106 Phenampromide N- (1-methyl-2- piperidinoethyl)propionanilide",
              "107 Phenazocine 2-hydroxy-5,9-dimethyl-2- phenethyl-6,7-benzomorphan",
              "108 Phenomorphan 3-hydroxy- N- phenethylmorphinan",
              "109 Phenoperidine 1-(3-hydroxy-3-phenylpropyl)-4- phenylpiperidine-4-carboxylic acid ethyl ester",
              "110 Piminodine 4-phenyl-1-(3- phenylaminopropyl)piperidine-4- carboxylic acid ethyl ester",
              "111 Piritramide 1-(3-cyano-3,3-diphenylpropyl)- 4-(1-piperidino)piperidine-4- carboxylic acid amide 112 Proheptazine 1,3-dimethyl-4-phenyl-4- propionoxyazacycloheptane",
              "113 Properidine 1-methyl-4-phenylpiperidine-4- carboxylic acid isopropyl ester",
              "114 Racemethorphan 4 ()-3-methoxy- N- methylmorphinan",
              "115 Racemoramide ()-4-[2-methyl-4-oxo-3,3- diphenyl-4-(1- pyrrolidinyl)butyl]morpholine",
              "116 Racemorphan 4 ()-3-hydroxy- N- methylmorphinan",
              "117 Remifentanil 1-(2-methoxycarbonylethyl)-4- (phenylpropionylamino)- piperidine-4-carboxylic acid methyl ester",
              "118 Sufentanil N- [4-(methoxymethyl)-1-[2-(2- thienyl)ethyl]-4- piperidyl]propionanilide",
              "119 Tetrahydrofuranyl N -phenyl- N -[1- fentanyl (THF-F)  (2-phenylethyl)piperidin-4- yl]tetrahydrofuran-2- carboxamide",
              "120 Thebacon Acetyldihydrocodeinone (acetylated enol form of hydrocodone)",
              "121 Thebaine 3,6-dimethoxy-17-methyl- 6,7,8,14-tetradehydro-4,5alpha- epoxymorphinan",
              "122 Thiofentanyl N- [1-[2-(2-thienyl)ethyl]-4- piperidyl]propionanilide",
              "123 Tilidine ()-ethyl- trans -2-(dimethylamino)- 1-phenyl-3-cyclohexene-1- carboxylate",
              "124 Trimeperidine 1,2,5-trimethyl-4-phenyl-4- propionoxypiperidine",
              "125 U-47700 3,4-dichloro- N- (2-dimethylamino- cyclohexyl)- N- methyl-benzamide",
              "126 Tramadol 2-[(Dimethylamino)methyl]-1-(3- methoxyphenyl)cyclohexanol 127 Pregabalin (3S)-3-(aminomethyl)-5- methylhexanoic acid",
              "128 Gabapentine 2-[1-(Aminomethyl)cyclohexyl]acetic acid",
              "1. The isomers, unless specifically excepted, of the dangerous drugs in this Section whenever the existence of such isomers is possible within the specific chemical designation.",
              "2. The esters and ethers, unless appearing in another part, of the dangerous drugs in this Section whenever the existence of such esters or ethers is possible.",
              "3. The salts of the dangerous drugs mentioned in this Section, including the salts of the isomers, whenever the formation of such salts is possible.",
              "4. Any   substance, that are substantially similar to the parent substances listed in this Section, which typically exhibiting high abuse potential.",
              "5. Any chemical analogue with modification in any of the atom of the parent  substance listed in this Section by any atom or specific group of atoms (functional group), which typically exhibiting high abuse potential.",
              "6. Substances, preparations or mixtures containing any proportion of a dangerous drug in this Section and isomers, esters and salts as specified in the paragraph 1, 2, 3, 4 and 5 above."
            ],
            "child_level_list": []
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "7",
        "text": "Any solution or dilution of morphine or cocaine or their salts in an inert substance whether liquid or solid containing any proportion of morphine or cocaine and any preparation, admixture, extracts, or other substances (not being such a solution or dilution as aforesaid) containing not less than 0.2  per centum of morphine or 0.1  per centum  of cocaine or ecgonine.",
        "pre_block_list": [
          "S ECTION  2",
          "1  Cannabinol and 6,6,9-Trimethyl-3- cannabinol pentyl-benzo[c]chromen-1-ol derivatives (CBN) 2  Cathinone ()-( S )-2-aminopropiophenone",
          "3  DET 3-[2-(diethylamino)ethyl]indole",
          "4  DMHP 3-(1,2-dimethylheptyl)-7,8,9,10- tetrahydro-6,6,9-trimethyl-6 H- dibenzo[b,d]pyran-  1-ol 5  DMT 3-[2-(dimethylamino)ethyl]indole",
          "6  DMA ()-2,5-dimethoxy-  - (2,5-Dimethoxy methylphenethylamine amphetamine)",
          "7  DOET ()-4-ethyl-2,5-dimethoxy-  - methylphenethylamine",
          "8  DOB ()-4-bromo-2,5- (Brolamfetamine) dimethoxy-  - methylphenethylamine",
          "9  DOC 4-Chloro-2,5- dimethoxyamfetamine",
          "10 Etryptamine 3-(2-aminobutyl)indole",
          "11(+)-Lysergide and N,N-Diethyl-D-lysergamide and other substances other  substances structurally structurally derived from  lysergamide by derived from substitution of any of the atoms, lysergamide",
          "12 Mescaline 3,4,5-trimethoxyphenethylamine",
          "13 MDMA(3,4-Methyl ()- N,  -dimethyl-3,4- enedioxymeth (methylenedioxy) amphetamine) phenethylamine 14 5-Methoxy-MDA 5-methoxy-  -methyl- (MMDA) 3,4- (methylenedioxy) phenethylamine",
          "15 Tenamfetamine  -methyl-3,4- (MDA) (methylenedioxy) phenethylamine",
          "16 4-Methylaminorex ()- cis -2-amino-4-methyl-5- phenyl-2-oxazoline",
          "17 Methcathinone 2-(methylamino)-1-phenylpropan- 1-one",
          "18 4-Methylthio  -methyl-4- amphetamine methylthiophenethylamine (4-MTA)",
          "19 N-Ethyl MDA ()- N- ethyl-  -methyl- (MDEA) 3,4- (methylenedioxy) phenethylamine",
          "20  N -Hydroxy MDA ()- N [  -methyl-3,4- (methylenedioxy) phenethyl]hydroxylamine",
          "21 25B-NBOMe 2-(4-bromo-2,5-dimethoxyphenyl) - N -(2-methoxybenzyl) ethanamine",
          "22 25C-NBOMe 2-(4-chloro-2,5-dimethoxyphenyl) - N -(2-methoxybenzyl) ethanamine",
          "23 25I-NBOMe 2-(4-iodo-2,5-dimethoxyphenyl)- N - (2-methoxybenzyl) ethanamine",
          "24 Parahexyl 3-hexyl-7,8,9,10-tetrahydro-6,6,9- trimethyl-6 H -dibenzo[ b,d ]pyran- 1-ol",
          "25 Eticyclidine (PCE) N -ethyl-1- phenylcyclohexylamine",
          "26 Rolicyclidine 1-(1-phenylcyclohexyl) (PCPy) pyrrolidine",
          "27 Psilocine (psilotsin, 3-[2- 4-HO-DMT) (dimethylamino) ethyl]indol-4-ol",
          "28 Psilocybine 3-[2-(dimethylamino)ethyl]indol- 4-yl dihydrogen phosphate",
          "29 p-Methoxyam 1-(4- phetamine (PMA) methoxyphenyl) propan-2-amine",
          "30 p-Methoxymetham 1-(4-methoxyphenyl)-2- phetamine (PMMA) methylaminopropane",
          "31 2,5-Dimethoxy-4- 2,5-dimethoxy-  ,4- methylamphetamine dimethylphenethylamine (STP, DOM) 32 Tenocyclidine (TCP) 1-[1-(2-thienyl)cyclohexyl] piperidine",
          "33 Tetrahydro- tetrahydrocannabinol, cannabinol (THC) the following isomers and their stereochemical variants:"
        ],
        "child_level_list": [
          {
            "class_name": "ActL3Paragraph",
            "num": "i",
            "text": "delta -6a(10a)-THC 7,8,9,10-tetrahydro-6,6,9- trimethyl-3-pentyl-6 H - dibenzo[ b,d ]pyran-1-ol",
            "pre_block_list": [],
            "child_level_list": [
              {
                "class_name": "ActL4SubParagraph",
                "num": "ii",
                "text": "delta -6a(7)-THC (9 R ,10a R )-8,9,10,10a-tetrahydro- 6,6,9-trimethyl-3-pentyl-6 H - dibenzo[b,d]pyran- 1-ol",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL4SubParagraph",
                "num": "iii",
                "text": "delta -7-THC (6a R ,9 R ,10a R )-6a,9,10,10a- tetrahydro-6,6,9-trimethyl-3- pentyl-6 H -dibenzo[b,d]pyran-1-ol",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL4SubParagraph",
                "num": "iv",
                "text": "delta -8-THC (6a R ,10a R )-6a,7,10,10a-tetrahydro- 6,6,9-trimethyl-3-pentyl-6 H - dibenzo[b,d]pyran-1-ol",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL4SubParagraph",
                "num": "v",
                "text": "delta -10-THC 6a,7,8,9-tetrahydro-6,6,9- trimethyl-3-pentyl-6 H - dibenzo[ b,d ]pyran-1-ol",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL4SubParagraph",
                "num": "vi",
                "text": "delta -9(11)-THC (6aR,10aR)-6a,7,8,9,10,10a- hexahydro-6,6-dimethyl-9- methylene3-pentyl-6H- dibenzo[b,d]pyran-1-ol 34 Trimethoxyam ()-3,4,5- trimethoxy-  - phetamine (TMA) methylphenethylamine",
                "pre_block_list": [
                  "35 Amphetamine ()-  -methylphenethylamine",
                  "36 Amineptine 7-[(10,11-dihydro-5 H - dibenzo[ a , d ]cyclohepten-5- yl)amino]heptanoic acid",
                  "37 AM-2201, [1-(5-Fluoropentyl)-1 H -indol-3- JWH-2201 yl](naphthalen-1-yl)methanone",
                  "38 5F-APINACA, N-(adamantan-1-yl)-1- 5F-AKB-48 (5-fluoropentyl)-1H-indazole-3- carboxamide",
                  "39 5F-AMB, 5F-AMB Methyl 2-({[1-(5- -PINACA fluoropentyl)-1H-indazol- 3yl]carbonyl}amino)-3- methylbutanoate",
                  "40 2C-B 4-bromo-2,5- dimethoxyphenethylamine",
                  "41 AB-CHMINACA N-[(2S)-1-amino-3-methyl- oxobutan-2-yl]-1- (cyclohexylmethyl)-1H-indazole-3- carboxamide 42 CUMYL-4CN- 1-(4-cyanobutyl)- N -(2- BINACA phenylpropan-2-yl)-1 H -indazole- 3-carboxamide",
                  "43 ADB-CHMINACA, N -[(2S)-1- amino-3,3- MAB-CHMINACA dimethyl-1-oxobutan-2-yl] -1-(cyclohexylmethyl)-1H- indazole-3-carboxamide",
                  "44 4-Chlorome 1-(4-chlorophenyl)-2- thcathinone, (methylamino)-1-propanone Clephedrone (4-CMC) 45 dexamphetamine (+)-  -methylphenethylamine",
                  "46 Dronabinol  (delta (6 aR ,10 aR )-6 a ,7,8,10 a - -9-tetrahydro- 6,6,9- trimethyl-3- pentyl-6H- cannabinol and its dibenzo[b,d]pyran-1-ol stereochemical variants)",
                  "47 Ethylone (RS)-1-(1,3-Benzodioxol-5-yl)-2- (ethylamino)propan-1-one",
                  "48 Ethylphenidate ethyl 2-phenyl-2-piperidin-2- ylacetate [1]",
                  "49 Fenetylline 7-[2-[(  -methylphenethyl) amino]ethyl]theophylline",
                  "50 4-Fluoroam 1-(4-Fluorophenyl) phetamine, 4-FA propan-2-amine",
                  "51 FUB-AMB, MMB- Methyl(2S)-2-({1-[4-fluorophenyl] FUBINACA, AMB-  methyl-1H- indazole-3 FUBINACA -carbonyl}amino)-3- methylbutanoate",
                  "52 ADB-FUBINACA N-[(2S)-1-amino-3,3-dimethyl-1- oxobutan-2-yl]-1-[(4- fluorophenyl)methyl]-1H- indazole-3-carboxamide",
                  "53 AB-FUBINACA N-[(2S)-1-amino-3-methyl-1- oxobutan-2-yl]-1-[(4- fluorophenyl)methyl]indazole-3- carboxamide",
                  "54   -Hydroxybutyric  -Hydroxybutyric acid acid (GHB ACID)",
                  "55 JWH-018, AM-678 Naphthalene-1-yl(1-pentyl-1 H - indol-3-yl)methanone",
                  "56 Ketamine 2-(Methylamino)-2-(2- chlorophenyl)cyclohexanone",
                  "57 Levamphetamine ()-( R )-  -methylphenethylamine (amphetamine(-) isomer",
                  "58 Levometham ()- N ,  -dimethylphenethylamine phetamine",
                  "59 Mecloqualone 3-( o -chlorophenyl)-2-methyl- 4(3 H )-quinazolinone",
                  "60 Methamphetamine (+)-( S )- N,  - (Methylamphetamine) dimethylphenethylamine 61 Methaqualone",
                  "2-methyl-3- o -tolyl-4(3 H )- quinazolinone",
                  "methyl   -phenyl-2-piperidine  acetate",
                  "62 Methylphenidate",
                  "()- N ,  -dimethylphenethylamine",
                  "63 Methamphetamine  racemate",
                  "(RS)-1-(Benzo[ d ][1,3]dioxol-5- pyrovalerone(MDPV) yl)-2- (pyrrolidin-1- yl)pentan-1-one",
                  "64 3,4-Methylenedioxy",
                  "65 Mephedrone, 4- (RS)-2-methylamino-1-(4- methylmethcathinone methylphenyl)propan-1-one 66 Methylone, (RS)-2-methylamino-1-(3,4- (beta-keto-MDMA) methylenedioxyphenyl) propan- 1-one",
                  "67 Methoxetamine (RS)-2-(3-methoxyphenyl)-2- (MXE) (ethylamino)-cyclohexanone",
                  "68 MDMB-CHMICA methyl 2-[[1-(cyclohexylmethyl) indole-3-carbonyl]amino]- 3,3dimethylbutanoate",
                  "69 Methiopropamine 1-(thiophen-2-yl)-2- (MPA) methylaminopropane",
                  "70 4-methylethcathinone 2-(Ethylamino)-1-(4-   (4-MEC) methylphenyl) propan-1-one",
                  "71 5F-MDMB-PICA Methyl(S)-2-(1-(5-fluoropentyl)-1 H - indole-3-carboxamido)-3,3- dimethylbutanoate",
                  "72 4F-MDMB-BINACA Methyl(S)-2-(1-(4-fluorobutyl)- 1H-indazole-3-carboxamido)-3,3- dimethylbutanoate 73  N -Benzylpiperazine 1-benzylpiperazine (BZP)",
                  "74  N- Ethylnorpentylone 1-(2H-1,3-benzodioxol-5-yl)-2- (ethylamino)pentan-1-one",
                  "75  N -Ethylhexedrone 2-(Ethylamino)-1-phenyl-1- hexanone",
                  "76 Phencyclidine (PCP) 1-(1-phenylcyclohexyl) piperidine",
                  "77 Phenmetrazine 3-methyl-2-phenylmorpholine",
                  "78 5F-ADB, 5F-MDMB Methyl(2S)-2-{[1- -PINACA (fluoropentyl)-1H-indazole-3- carbonyl] amino}-3,3- dimethylbutanoate 79 AB-PINACA N-[(2S)-1-Amino-3-methyl-1- oxobutan-2-yl]-1-pentyl-1H- indazole-3-carboxamide",
                  "80  alpha -PVP  -pyrrolidinovalerophenone",
                  "81 4,4-dimethylaminorex   para -methyl- (4,4-DMAR) 4-methylaminorex",
                  "82 Pentedrone ()-2-(methylamino)-1- phenylpentan-1-one",
                  "83 5F-PB-22 Quinolin-8-yl 1-(5-fluoropentyl)- 1 H -indole-3-carboxylate",
                  "84  alpha -PHP (RS)-1-Phenyl-2-(pyrrolidine-1- yl)hexan-1-one",
                  "85 Secobarbital 5-allyl-5-(1- methylbutyl)barbituric acid",
                  "86 UR-144 (1-Pentyl-1 H -indol-3-yl)(2,2,3,3- tetramethylcyclopropoyl) methanone",
                  "87 XLR-11 [1-(5-Fluoropentyl)-1H-indol-3-yl] (2,2,3,3tetramethylcyclopropyl) methanone",
                  "88 Zipeprol  -(  -methoxybenzyl)-4-(  - methoxyphenethyl)-1- piperazineethanol",
                  "89 Amobarbital 5-ethyl-5-isopentylbarbituric acid",
                  "90 Butalbital 5-allyl-5-isobutylbarbituric acid",
                  "91 Buprenorphine 2l-cyclopropyl-7-  -[(S)-1-hydroxy- 1,2,2-trimethylpropyl]-6,14-endo- ethano-  6,7,8,14- tetrahydrooripavine 92 Cyclobarbital 5-(1-cyclohexen-1-yl)-5- ethylbarbituric acid",
                  "93 (+)-Norpseudoe 2-amino-1-hydroxy-1 phedrine -phenylpropane (including Cathine) 94 Flunitrazepam 5-( o -fluorophenyl)-1,3-dihydro-1- methyl-7-nitro-2 H -1,4- benzodiazepin-2-one",
                  "95 Glutethimide 2-ethyl-2-phenylglutarimide",
                  "96 Pentobarbital 5-ethyl-5-(1- methylbutyl)barbituric acid",
                  "97 Pentazocine (2 R *,6 R *,11 R *)-1,2,3,4,5,6- hexahydro-6,11-dimethyl-3-(3- methyl-2-butenyl)-2,6-  methano-3- benzazocin-8-ol 98 diethylpropion 2-(diethylamino)propiophenone",
                  "99 Alprazolam 8-chloro-1-methyl-6-phenyl-4 H - s - triazolo[4,3-a][1,4] benzodiazepine",
                  "100 Allobarbital 5,5-diallylbarbituric acid",
                  "101 Aminorex 2-amino-5-phenyl-2-oxazoline",
                  "102 Barbital 5,5-diethylbarbituric acid",
                  "103 Benzphetamine N -benzyl- N ,  - dimethylphenethylamine",
                  "104 Bromazepam 7-bromo-1,3-dihydro-5-(2- pyridyl)-2 H -1,4- benzodiazepin-2- one",
                  "105 Butobarbitone 5-butyl-5- (Butobarbital) ethylbarbituricacid",
                  "106 Brotizolam 2-bromo-4-( o - chlorophenyl) -9- methyl- 6 H -thieno[3,2-f]-s- triazolo[4,3-  a][1,4]diazepine",
                  "107 Camazepam 7-chloro-1,3-dihydro-3-hydroxy-1- methyl-5-phenyl- 2 H -1,4- benzodiazepin-2-one dimethylcarbamate (ester) 108 Chlordiazepoxide 7-chloro-2-(methylamino)-5- phenyl-3 H -1,4- benzodiazepine-4- oxide",
                  "109 Clobazam 7-chloro-1-methyl-5-phenyl-1 H - 1,5-benzodiazepine- 2,4(3 H ,5 H )- dione",
                  "110 Clonazepam 5-( o- chlorophenyl)-1,3-dihydro-7- nitro-2 H -1,4- benzodiazepin-2-one",
                  "111 Clorazepate 7-chloro-2,3-dihydro-2-oxo-5- phenyl-1 H -1,4- benzodiazepine-3- carboxylic acid",
                  "112 Clotiazepam 5-( o -chlorophenyl)-7-ethyl-1,3- dihydro-1-methyl-2 H - thieno[2,3- e ]-1,4-diazepin- 2-one",
                  "113 Cloxazolam 10-chloro-11b-( o -chlorophenyl)- 2,3,7,11b-tetrahydro- oxazolo- [3,2- d ][1,4]benzodiazepin-6(5 H )- one 114 Delorazepam 7-chloro-5-( o -chlorophenyl)-1,3- dihydro-2 H -1,4- benzodiazepin-2- one",
                  "115 Diazepam 7-chloro-1,3-dihydro-1-methyl-5- phenyl-2 H -1,4- benzodiazepin-2- one",
                  "116 Ethchlorvynol 1-chloro-3-ethyl-1-penten-4-yn-3- ol",
                  "117 Ethinamate 1-ethynylcyclohexanolcarbamate",
                  "118 Estazolam 8-chloro-6-phenyl-4 H - s -triazolo[4,3- a][1,4]benzodiazepine",
                  "119 Ethyl loflazepate ethyl 7-chloro-5-( o -fluorophenyl)- 2,3-dihydro-2-oxo- 1 H -1,4- benzodiazepine-3- carboxylate 120  N -ethylamphetamine N -ethyl-  -methylphenethylamine 121 Etizolam 4-(2-Chlorophenyl)-2-ethyl-9-methyl- 6H-thieno[3,2- f][1,2,4] triazolo [4,3a][1,4] diazepine 122 Fludiazepam 7-chloro-5-( o -fluorophenyl)-1,3- dihydro-1-methyl-2 H - 1,4- benzodiazepin-2-one",
                  "123 Flurazepam 7-chloro-1-[2-(diethylamino)ethyl]-5- ( o -fluorophenyl)- 1,3-dihydro-2 H -1,4- benzodiazepin-2-one 124 Fencamfamin N -ethyl-3-phenyl-2- norbornanamine",
                  "125 Fenproporex ()-3-[(  -methylphenylethyl) amino]propionitrile",
                  "126 Flualprazolam 8-Chloro-6-(2-fluoro-phenyl)-1- methyl-4h- benzo[f][1,2,4]triazolo[4,3- a][1,4] diazepime",
                  "127 Halazepam 7-chloro-1,3-dihydro-5-phenyl-1- (2,2,2-trifluoroethyl)- 2 H -1,4- benzodiazepin-2-one",
                  "128 Haloxazolam 10-bromo-11b-( o -fluorophenyl)- 2,3,7,11b- tetrahydrooxazolo[3,2- d ] [1,4]benzodiazepin- 6(5 H )-one",
                  "129 Ketazolam 11-chloro-8,12b-dihydro-2,8- dimethyl-12b-phenyl-4 H - [1,3]oxazino[3,2- d ][1,4]benzodiazepin-4,7(6 H )- dione 130 Lefetamine (SPA) ()- N,N -dimethyl-1,2- diphenylethylamine",
                  "131 Loprazolam 6-( o -chlorophenyl)-2,4-dihydro-2- [(4-methyl-1- piperazinyl)methylene]-8-nitro- 1 H -imidazo[1,2- a ][1,4]benzodiazepin-1-one 132 Lorazepam 7-chloro-5-( o -chlorophenyl)-1,3- dihydro-3-hydroxy-2 H - 1,4- benzodiazepin-2-one",
                  "133 Lormetazepam 7-chloro-5-( o -chlorophenyl)-1,3- dihydro-3-hydroxy-1- methyl-2 H - 1,4- benzodiazepin-2-one 134 Mazindol 5-( p -chlorophenyl)-2,5-dihydro- 3 H -imidazo[2,1-a]isoindol-5-ol",
                  "135 Meprobamate 2-methyl-2-propyl-1,3- propanedioldicarbamate",
                  "136 Methylphenobarbital 5-ethyl-1-methyl-5- phenylbarbituric acid",
                  "137 Methyprylon 3,3-diethyl-5-methyl-2,4- piperidine-dione",
                  "138 Medazepam 7-chloro-2,3-dihydro-1-methyl-5- phenyl-1 H -1,4- benzodiazepine",
                  "139 Mefenorex N -(3-chloropropyl)-  - methylphenethylamine",
                  "140 Midazolam 8-chloro-6-( o -fluorophenyl)-1- methyl-4 H - imidazo[1,5- a ][1,4]benzodiazepine",
                  "141 Mesocarb 3-(  -methylphenethyl)- N - (phenylcarbamoyl)sydnone imine",
                  "142 Nimetazepam 1,3-dihydro-1-methyl-7-nitro-5- phenyl-2 H -1,4-benzodiazepin-2- one",
                  "143 Nitrazepam 1,3-dihydro-7-nitro-5-phenyl-2 H - 1,4-benzodiazepin-2-one",
                  "144 Nordazepam 7-chloro-1,3-dihydro-5-phenyl- 2 H -1,4-benzodiazepin-2-one",
                  "145 Oxazepam 7-chloro-1,3-dihydro-3-hydroxy- 5-phenyl-2 H -1,4-benzodiazepin- 2-one",
                  "146 Oxazolam 10-chloro-2,3,7,11b-tetrahydro-2- methyl-11b-phenyloxazolo[3,2- d ][1,4]benzodiazepin- 6(5 H )-one 147 Phendimetrazine (+)-(2 S ,3 S )-3,4-dimethyl-2- phenylmorpholine",
                  "148 Phenobarbital 5-ethyl-5-phenylbarbituric acid",
                  "149 Phentermine  ,  -dimethylphenethylamine",
                  "150 Pipradrol 1,1 - diphenyl-1-(2-piperidyl) methanol",
                  "151 Pinazepam 7-chloro-1,3-dihydro-5-phenyl-1- (2-propynyl)-2 H - 1,4- benzodiazepin-2-one",
                  "152 Prazepam 7-chloro-1-(cyclopropylmethyl)-1,3- dihydro-5-   phenyl-2 H -1,4- benzodiazepin-2-  one 153 Pyrovalerone 4-methyl-2-(1- pyrrolidinyl) valerophenone",
                  "154 Pemoline 2-amino-5-phenyl-2-oxazolin-4- one",
                  "155 Phenazepam 7-bromo-5-(2-chlorophenyl) (Fenazepam) -1,3-dihydro-2H- 1,4- benzodiazepin-2-one",
                  "156 Secbutabarbital 5- sec -butyl-5-ethylbarbituric acid",
                  "157 Temazepam 7-chloro-1,3-dihydro-3-hydroxy- 1-methyl-5-phenyl- 2 H -1,4- benzodiazepin-2-one",
                  "158 Tetrazepam 7-chloro-5-(1-cyclohexen-1-yl)-1,3- dihydro-1-   methyl-2 H -1,4- benzodiazepin-2-  one 159 Triazolam 8-chloro-6-( o- chlorophenyl)-1- methyl-4 H - s - triazolo[4,3-  a ][1,4] benzodiazepine",
                  "160 Vinylbital 5-(1-methylbutyl)-5-vinylbarbituric acid",
                  "161 Zolpidem N , N ,6-trimethyl-2- p -tolylimidazo [1,2- a ]pyridine-3-acetamide",
                  "1 .  The isomers, unless specifically excepted, of the drugs in this Section whenever the existence of such isomers is possible within the specific chemical designation.",
                  "2.  The esters and ethers, unless appearing in another part, of the drugs in this Section whenever the existence of such esters or ethers is possible.",
                  "3.  The salts of the dangerous drugs mentioned in this Section, including the salts of the isomers, whenever the formation of such salts is possible.",
                  "4.  Any  substance, that are substantially similar to the parent substances listed in this Section, which typically exhibiting high abuse potential.",
                  "5.  Any chemical analogue with modification in any of the atom of the parent  substance listed in this Section by any atom or specific group of atoms (functional group), which typically exhibiting high abuse potential.",
                  "6.  Substances, preparations or mixtures containing any proportion of drug/drugs in this Section and isomers, esters and salts as specified in the paragraphs 1, 2, 3, 4 and 5 above.",
                  "S ECTION  3",
                  "The groups of  substances, including any salt or sterioisomeric form of such substances and any preparation, mixture or a product containing such substances as indicated below:",
                  "1.  Amphetamine analogues , other than listed in the above Section 2, in which the 1-amino-2- phenylethane nucleus carries any of the following substituent, either alone or in combination:",
                  "( a ) 1 or 2 alkyl substituents, each with up to 6 carbon atoms, attached to the nitrogen atom;",
                  "( b ) 1 or 2 methyl substituents or an ethyl substituent, attached to the carbon atom adjacent to the nitrogen atom;",
                  "( c ) a hydroxy substituent attached to the carbon atom adjacent to the benzene ring;",
                  "( d ) any combination of up to 5 alkyl substituent and/or alkoxy substituent and/or alkylamino substituent and/ or alkylthio substituent (each with up to 6 carbon atoms, including cyclic substituent) and/or halogen substituent and/or nitro substituent and/or amino substituent, attached to the benzene ring.",
                  "2. Pethidine analogues , in which any  substance (not being listed in above Section 1) structurally derived from pethidine (4-phenylpiperidine nucleus) by modification in any of the atom by any atom or specific group of atoms (functional group) or stereoisomeric form of any such substance, any preparation or product containing any such substance and thereof, any of the following ways:-",
                  "( a ) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;",
                  "(b ) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;",
                  "(c ) by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogen or haloalkyl groups;",
                  "(d ) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;",
                  "(e ) by formation of an N-oxide or of a quaternary base.",
                  "3. Phencyclidine analogues , any  substance other than listed in the above Section 2, being chemical   substances with the 1-alkylamino-1-arylcyclohexane (arylcycloalkylamines) structure, with any combination of the followings:-",
                  "(a ) the alkylamino  substituent  is 1-piperidinyl, 1-pyrrolidinyl, 4-morpholinyl, or any other substituent with up to 6 carbon atoms in the alkyl portion;",
                  "(b ) the aryl substituent is phenyl, thienyl, pyridinyl, or pyrrolidinyl;",
                  "(c ) the aryl substituent, carries any combination of up to 5 alkyl substituents and/or alkoxy substituent (each with up to 6 carbon atoms, including cyclic substituents) and/or halogen substituents;",
                  "(d ) any related  substances, including any salt or stereoisomeric form of such substances, and any preparation or product containing such substances.",
                  "4. Fentanyl analogues,  any  substance other than listed in above Section 1, in which the N-[1-(2- phenethyl)-4-piperidyl]aniline nucleus has additional substituents, either alone or in combination or by any modification attached as follows:-",
                  "(a ) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;",
                  "(b ) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogen, haloalkyl, amino or nitro groups;",
                  "(c ) by substitution in the piperidine ring with alkyl or alkenyl groups;",
                  "(d ) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogen or haloalkyl groups;",
                  "(e ) by substitution at the 4-position of the piperidine ring with anyalkoxycarbonyl or alkoxyalkyl or acyloxy group;",
                  "(f ) by replacement of the N-propionyl group by another acyl group; or",
                  "( g ) any  substances (other than a substance listed in Section 1), structurally derived from (1-Methyl- 4-piperidyl)- N-phenylformamide by any substitution and thereof.",
                  "5. Methaqualone analogues , any  substance other than listed in the above Section 2, in which the 3- arylquinazolin-4-one nucleus has additional substituents, either alone or in combination, attached as follows:",
                  "( a ) an alkyl substituent, with up to 6 carbon atoms, attached at the 2 position;",
                  "( b ) any combination of up to 5 alkyl substituents and/or alkoxy substituents (each with up to 6 carbon atoms, including cyclic substituents) and/or halogen substituents, attached to each of the aryl rings.",
                  "6. Tryptamines analogues,  which any  substance (other than a substance listed in the above Section 2 or serotonin) structurally derived from 2-(1Hindol-3-yl) ethanamine (tryptamine) or from a ring- hydroxy by modification in any of the atom by any atom or specific group of atoms (functional group), including any ether, salt or stereoisomeric form of any such substance, any preparation or product containing any such substance and thereof, such as-",
                  "( a ) by substitution at the nitrogen atom of the side chain to any extent with alkyl or alkenyl substituents or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in acyclic structure;",
                  "( b ) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;",
                  "( c ) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents;",
                  "( d ) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent.",
                  "7. Synthetic Cathinones and their analogues.",
                  "Any  substance, (other than a substance listed in the above Section 2 or bupropion) that is structurally derived from 2- amino-1-phenylpropan-1-one by modification in any of the atom by any substitution by an atom or a specific group of atoms (functional group) or substituent including any salt or stereoisomeric form thereof, and any preparation or product containing thereof."
                ],
                "child_level_list": []
              }
            ]
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "8",
        "text": "Aminodanes and their analogues.",
        "pre_block_list": [
          "Any aminodane (other than listed in the above Sections) and any  substance, including any salt or stereoisomeric form of such substances, and any preparation or product containing such   substances."
        ],
        "child_level_list": []
      },
      {
        "class_name": "ActL1Section",
        "num": "9",
        "text": "Phenethylamines and their analogues.",
        "pre_block_list": [
          "Any phenethylamine  substance (other than a substance listed in the above Section 2), including any type of positional isomer in the phenyl ring by modification in any of the atom by any substitution by an atom or a specific group of atoms (functional group), substituted substances such as the 2C series, ring substituted amphetamines such as the D series, any benzodifurans or its substituent and any others substance thereof, including any salt or stereoisomeric form thereof, and any preparation or product containing thereof."
        ],
        "child_level_list": []
      },
      {
        "class_name": "ActL1Section",
        "num": "10",
        "text": "Any  substance (not being bupropion, cathinone, diethylpropion, pyrovalerone or not being listed for the time being specified in above Sections) structurally derived from 2amino1phenyl 1 propanone by modification in any of the following ways, that is to say-",
        "pre_block_list": [],
        "child_level_list": [
          {
            "class_name": "ActL3Paragraph",
            "num": "a",
            "text": "by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "b",
            "text": "by substitution at the 3position with an alkyl substituent;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "c",
            "text": "by substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.",
            "pre_block_list": [],
            "child_level_list": []
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "11",
        "text": "Any  substance (other than a substance listed in above Sections) structurally derived from 2 aminopropan1one by substitution at the 1-position with any monocyclic or fused- polycyclic ring system or not being listed for the time being specified in above Sections or not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the substance is further modified in any of the following ways, that is to say-",
        "pre_block_list": [],
        "child_level_list": [
          {
            "class_name": "ActL3Paragraph",
            "num": "a",
            "text": "by substitution in the ring system to any extent with alkyl, alkoxy, alkylenedioxy haloalkyl or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "b",
            "text": "by substitution at the 3position with an alkyl substituent;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "c",
            "text": "by substitution at the 2-amino nitrogen atom with alkyl or dialkyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.",
            "pre_block_list": [],
            "child_level_list": []
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "12",
        "text": "Any  substance (not being listed in above Sections or not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the substance is further modified in any of the following ways, that is to say-",
        "pre_block_list": [],
        "child_level_list": [
          {
            "class_name": "ActL3Paragraph",
            "num": "a",
            "text": "by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "b",
            "text": "by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "c",
            "text": "by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group.",
            "pre_block_list": [],
            "child_level_list": []
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "13",
        "text": "Any substance falls into the category of  Synthetic Cannabinoids  (other than listed in above Section 2), any salt or stereoisomeric form of such  substances, and any preparation or product containing such substances:",
        "pre_block_list": [],
        "child_level_list": [
          {
            "class_name": "ActL3Paragraph",
            "num": "a",
            "text": "Any  substance other than listed in above Section 2, containing a 3-(1-naphthylmethyl)indole structure with substitution at the nitrogen atom of the indole ring by an atom or any specific group of atoms (functional group), and any derivatives of the above substances including any salt or stereoisomeric form of the above substances or derivatives, and any preparation or product containing the above substances or derivatives;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "b",
            "text": "Any  substance other than listed in above Section 2, containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an atom or any specific group of atoms (functional group), and any derivatives of the above substances containing functional groups, including any salt or stereoisomeric form of the above substances or derivatives, and any preparation or product containing the above substances or derivative;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "c",
            "text": "Any  substance other than listed in above Section 2, containing a naphthylideneindene structure with any substitution at any position of the indene ring by an atom or any specific group of atoms (functional group), and any derivatives of the above substances containing hydroxy and/or carboxylic acid groups, including any salt or stereoisomeric form of the above substances or derivatives, and any preparation or product containing the above substances or derivatives;",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "d",
            "text": "Any  substance other than listed in above Section 2, containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at any position of the phenolic ring by an atom or any specific group of atoms (functional group), and any derivatives of the above substances containing hydroxy and/or carboxylic acid groups, including any salt or stereoisomeric form of the above substances or derivatives, and any preparation or product containing the above substances or derivatives.",
            "pre_block_list": [],
            "child_level_list": []
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "14",
        "text": "The analogues  gamma-Hydroxybutyrate (GHB)  and",
        "pre_block_list": [],
        "child_level_list": [
          {
            "class_name": "ActL3Paragraph",
            "num": "a",
            "text": "the esters, ethers, and amides of GHB; and",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "b",
            "text": "all substances from which GHB can be derived, including (without limitation)",
            "pre_block_list": [],
            "child_level_list": [
              {
                "class_name": "ActL4SubParagraph",
                "num": "i",
                "text": "1,4-butanediol;",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL4SubParagraph",
                "num": "ii",
                "text": "gamma-aminobutyric acid;",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL4SubParagraph",
                "num": "iii",
                "text": "gamma-butyrolactone;",
                "pre_block_list": [],
                "child_level_list": []
              },
              {
                "class_name": "ActL4SubParagraph",
                "num": "iv",
                "text": "gamma-hydroxybutyraldehyde; and",
                "pre_block_list": [],
                "child_level_list": []
              }
            ]
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "c",
            "text": "the salts of GHB (including sodium oxybate) and the salts of any substance referred to in paragraph ( a ) or paragraph ( b ); and",
            "pre_block_list": [],
            "child_level_list": []
          },
          {
            "class_name": "ActL3Paragraph",
            "num": "d",
            "text": "any substance, preparation, or mixture containing any proportion of GHB or any substance referred to in any of paragraphs ( a ) to ( c ).",
            "pre_block_list": [],
            "child_level_list": []
          }
        ]
      },
      {
        "class_name": "ActL1Section",
        "num": "15",
        "text": "Plant based substances causing a psychoactive effect",
        "pre_block_list": [
          "Any part of the plant other than listed in above Sections 1 and 2, any extract or preparation thereof of the following plants:",
          "( b ) Kratom ( Mitragyna speciosa );",
          "( c ) Salvia ( Salvia divinorum );",
          "( d ) Chacruna ( Psychiotria viridis );",
          "( e ) Mimosa hostilis ( Mimosa tenuiflora );",
          "( f ) Hawaiian Baby Woodrose ( Argyreia nervosa );",
          "( g ) Iboga ( Tabernanthe iboga ),",
          "or any other plant containing any dangerous drug or a substance substantially similar to dangerous drugs or an substituted analogue of a dangerous drug listed in above Sections 1 and 2, which typically exhibiting high abuse potential",
          ""
        ],
        "child_level_list": [
          {
            "class_name": "ActL2Subsection",
            "num": "2",
            "text": "by the repeal of Part III of that Schedule and the substitution therefor of the following Part:-",
            "pre_block_list": [],
            "child_level_list": []
          }
        ]
      }
    ],
    "part_list": [
      {
        "class_name": "ActL0Part",
        "num": "III",
        "text": "",
        "pre_block_list": [
          "PART III",
          "Traffics, Opium possess, imports or exports",
          "-do- 1 kilogramme or above",
          "Death or life imprisonment.",
          "Life imprisonment.",
          "-do- 500 grammes to less than 1 kilogramme",
          "Fine not less than Two Hundred Thousand Rupees and not exceeding Five Hundred Thousand Rupees and imprisonment of either description for a period not less than ten years and not exceeding fifteen years or to both such fine and imprisonment.",
          "-do- 50 grammes to less than 500 grammes",
          "Fine not less than One Hundred Thousand Rupees and not exceeding Two Hundred Thousand Rupees and imprisonment of either description for a period not less than five years and not exceeding ten years or to both such fine and imprisonment.",
          "-do- 10 grammes to less than 50 grammes",
          "-do- Less than 10 grammes",
          "Fine not exceeding One Hundred Thousand Rupees and imprisonment of either description for a period not less than two years and not exceeding five years or to both such fine and imprisonment.",
          "Morphine, Cocaine, Heroin and Methamphetamine",
          "-do- 5 grammes or  Death or life imprisonment.  above",
          "-do-",
          "3 grammes to less than 5 grammes",
          "Fine not less than Two Hundred Thousand Rupees and not exceeding Five Hundred Thousand Rupees and imprisonment of either description for a period not less than ten years and not exceeding twenty years or to both such fine and imprisonment.",
          "-do-",
          "2 grammes to less than 3 grammes",
          "Fine not less than One Hundred Thousand Rupees and not exceeding Two Hundred Thousand Rupees and imprisonment of either description for a period not less than seven years and not exceeding ten years or to both such fine and imprisonment.",
          "Fine not less than Twenty Five Thousand Rupees and not exceeding Fifty  Thousand  Rupees  and imprisonment of either description for a period not less than three years and not exceeding five years or to both such fine and imprisonment.",
          "Less than 2 grammes",
          "-do-",
          "Cannabis",
          "Fine not less than Two Hundred Thousand Rupees and not exceeding Five Hundred Thousand Rupees and imprisonment of either description for a period not less than ten years and not exceeding fifteen years or to both such fine and imprisonment.",
          "100 kilogrammes or above",
          "-do-",
          "-do-",
          "5 kilogrammes to less than 100 kilogrammes",
          "Fine not less than One Hundred Thousand Rupees and not exceeding Two Hundred Thousand Rupees and imprisonment of either description for a period not less than five years and not exceeding ten years or to both such fine and imprisonment.",
          "1 kilogramme to less than 5 kilogrammes",
          "-do-",
          "Fine not less than Fifty Thousand Rupees and not exceeding One Hundred Thousand Rupees and imprisonment of either description for a period not less than two years and not exceeding five years or to both such fine and imprisonment.",
          "Fine not less than Twenty Thousand Rupees and not exceeding Fifty Thousand Rupees and imprisonment of either description for a period not less than one year and not exceeding two years or to both such fine and imprisonment.",
          "Less than 1 kilogramme",
          "-do-"
        ],
        "child_level_list": [
          {
            "class_name": "ActL1Section",
            "num": "7",
            "text": "For the avoidance of doubt, it is hereby declared that the provisions of section 6 shall not apply in respect of an offence which was committed prior to the date of coming into operation of this Act.",
            "pre_block_list": [
              "Avoidance of doubt"
            ],
            "child_level_list": []
          },
          {
            "class_name": "ActL1Section",
            "num": "8",
            "text": "In the event of any inconsistency between the Sinhala and Tamil texts of this Act, the Sinhala text shall prevail.",
            "pre_block_list": [
              "Sinhala text to prevail in case of inconsistency",
              "English Acts of the Parliament can be purchased at the P RAKASHANA  P IYASA , D EPARTMENT   OF G OVERNMENT  P RINTING , N O . 118, D R . D ANISTER  D E  S ILVA  M AWATHA , C OLOMBO  8."
            ],
            "child_level_list": []
          }
        ]
      }
    ]
  }
}